Eternity Insights can provide a deep-dive research report highlighting the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Pharmacovigilance market. The report considers 2019-2022 historic period, 2023 as base year, and 2024-2034 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Pharmacovigilance market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid databases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Pharmacovigilance market is estimated to expand at a considerable growth rate during the forecast period owing to the increasing prevalence of venous diseases and increasing new product approvals to cater to this demand. Increased awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of Pharmacovigilance products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Pharmacovigilance products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Pharmacovigilance market.
To learn more about this report
Increasing research and development spending on Pharmacovigilance development has been the leading industry trend of Pharmacovigilance market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be witnessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
Report Attributes | Details |
The market size value in 2023 | USD XX.XX Million |
CAGR (2024 - 2034) | XX.XX % |
The Revenue forecast in 2034 | USD XX.XX Million |
Base year for estimation | 2023 |
Historical data | 2019-2022 |
Forecast period | 2024-2034 |
Quantitative units |
|
Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments Covered | By Type, Product Life Cycle, Service Provider, Therapeutic Area, Process Flow, End-Use Outlook, Regional Outlook |
By Type Outlook | Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining |
By End-Use Outlook | Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, Others |
Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
Key companies profiled | Accenture, IQVIA Inc., Cognizant, Clinquest Group B.V. (Linical Americas), IBM, Laboratory Corporation of America Holdings, ArisGlobal, Capgemini, ITClinical, ICON plc., TAKE Solutions Limited, Parexel International (MA) Corporation, Wipro, United BioSource LLC, BioClinica Inc. (Clario), ClinChoice (formerly FMD K&L) |
Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Pharmacovigilance Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Pharmacovigilance Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Pharmacovigilance Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Pharmacovigilance Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Chemotherapy
4.2.2 Contract Outsourcing
4.2.3 Other
4.4 Type Comparison Matrix
4.5 Global Pharmacovigilance Market Attractiveness, By Type
5 Global Pharmacovigilance Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Pharmacovigilance Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Pharma and Biotech Companies
5.3.2 Contract Research Organizations (CROs)
5.3.3 Business Process Outsourcing (BPO) Firms
5.3.4 Others
5.4 Application Comparison Matrix
5.5 Global Pharmacovigilance Market Attractiveness, by Application
6 Global Pharmacovigilance Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Pharmacovigilance Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Pharmacovigilance Market Attractiveness, by Region
8 North America Pharmacovigilance Market Analysis and Forecast
8.1 Key Findings
8.2 North America Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Chemotherapy
8.2.2 Contract Outsourcing
8.2.3 Other
8.3 North America Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Pharma and Biotech Companies
8.3.2 Contract Research Organizations (CROs)
8.3.3 Business Process Outsourcing (BPO) Firms
8.3.4 Others
8.4 North America Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Pharmacovigilance Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Pharmacovigilance Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Chemotherapy
9.2.2 Contract Outsourcing
9.2.3 Other
9.3 Europe Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Pharma and Biotech Companies
9.3.2 Contract Research Organizations (CROs)
9.3.3 Business Process Outsourcing (BPO) Firms
9.3.4 Others
9.4 Europe Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Pharmacovigilance Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Pharmacovigilance Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Chemotherapy
10.2.2 Contract Outsourcing
10.2.3 Other
10.3 Asia Pacific Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Pharma and Biotech Companies
10.3.2 Contract Research Organizations (CROs)
10.3.3 Business Process Outsourcing (BPO) Firms
10.3.4 Others
10.4 Asia Pacific Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Pharmacovigilance Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Pharmacovigilance Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Chemotherapy
11.2.2 Contract Outsourcing
11.2.3 Other
11.3 Latin America Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Pharma and Biotech Companies
11.3.2 Contract Research Organizations (CROs)
11.3.3 Business Process Outsourcing (BPO) Firms
11.3.4 Others
11.4 Latin America Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Pharmacovigilance Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Pharmacovigilance Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Chemotherapy
12.2.2 Contract Outsourcing
12.2.3 Other
12.3 Middle East & Africa (MEA) Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Pharma and Biotech Companies
12.3.2 Contract Research Organizations (CROs)
12.3.3 Business Process Outsourcing (BPO) Firms
12.3.4 Others
12.4 Middle East & Africa (MEA) Pharmacovigilance Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Pharmacovigilance Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Eli Lilly and Company
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 ICON
13.3.3 Elsevier
13.3.4 Chiltern
13.3.5 Atlantic Research Group
13.3.6 Mapi Group
13.3.7 Accenture
13.3.8 Clinquest Group
13.3.9 GSK
13.3.10 PRA Health Sciences
14 Key Takeaways
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing